Prostate cancer is a malignancy of one of the major male sex glands, in which cells of the prostate become abnormal and start to grow uncontrollably, forming tumors.
Researchers discover 5 inherited genetic variants linked to the most lethal prostate cancers – An international team of researchers led by Fred Hutchinson Cancer Research Center has identified five inherited genetic variants that are strongly associated with aggressive, lethal prostate cancer.
Urine test shows prostate cancer risk, U-M study finds — Test for gene fusion can assist in the early detection of prostate cancer – A new urine test can help aid early detection of and treatment decisions about prostate cancer. Examining the urine sample for TMPRSS2:ERG and PCA3 and stratified patient into low, intermediate and high score, indicating their risk of cancer can help.
Successfully tested in Rwanda, mChip diagnoses infectious diseases like HIV and syphilis at patients’ bedsides; new device could streamline blood testing worldwide – New low-cost diagnostics like the mChip can revolutionize medical care around the world, revealed by researcher in US. Microfluidics-the manipulation of small amounts of fluids-and nanoparticles can be successfully leveraged to produce a functional low-cost diagnostic device in extreme resource-limited settings.
RNZCGP welcomes prostate cancer inquiry results – Encouraging men to seek up-to-date evidenced-based information from their GPs about screening and treatment of prostate cancer disease and screening for prostate cancer is recommended. The Royal New Zealand College of General Practitioners (RNZCGP) has welcomed the release of the results of the Health Select Committee’s inquiry into the early detection and treatment of prostate cancer.
Smoking may increase risk of prostate cancer recurrence, death – Researchers found that men with prostate cancer who were current smokers had a 61% increased risk of dying from prostate cancer, and a 61% higher risk of recurrence compared with men who never smoked. This new study from Harvard School of Public Health (HSPH) and University of California, San Francisco, researchers suggests that men with prostate cancer who smoke increase their risk of prostate cancer recurrence and of dying from the disease.
Brisk walking may help men with prostate cancer, UCSF study finds – Men with prostate cancer can improve their outcomes if they walk briskly for at least three hours a week following their diagnosis, according to a recent study in Cancer Research, a journal of the American Association for Cancer Research.
Coffee may reduce risk of lethal prostate cancer in men – It is a good news for men who regularly drink coffee. They appear to have a lower risk of developing a lethal form of prostate cancer, revealed by researchers from Harvard School of Public Health (HSPH) US.
Obesity linked to higher risk of prostate cancer progression – Even when treated with hormone therapy to suppress tumor growth, obese men face an elevated risk of their prostate cancer worsening, researchers at Duke University Medical Center have found.
Advanced-stage prostate cancer patients experience 20-year survival rates with surgery – Long-term survival rates for patients with advanced prostate cancer suggest they can be good candidates for surgery, Mayo Clinic researchers have found. Their study found a 20-year survival rate for 80 percent of patients diagnosed with cancer that has potentially spread beyond the prostate, known as cT3 prostate cancer, and treated with radical prostatectomy, or surgery to remove the prostate gland.
U.S. Food and Drug Administration (FDA) approves Zytiga for late-stage prostate cancer – The U.S. Food and Drug Administration approved Zytiga (abiraterone acetate) in combination with prednisone (a steroid) to treat patients with late-stage (metastatic) castration-resistant prostate cancer who have received prior docetaxel (chemotherapy).
